Synopsis:Management of this company projected around 70 percent revenue growth in FY27 and raised its full-year revenue guidance, bringing this stock into the spotlight.
The shares of this company, which is an Indian manufacturer and global exporter of male condoms, female condoms, lubricants, and IVD kits, gained investor focus after giving a strong Q1 outlook
With a market capitalization of Rs 26,093 crore, Cupid Ltd’s shares on Wednesday made a day high of Rs 194.25 per share, up 2.3 percent from the previous day’s close price of Rs 189.85 per share. The share of the company gave a return of 786 percent over the last year.
Q1 Key Highlights
Management Raises FY27 Revenue Guidance
Cupid Limited said it is on track to report revenue of more than Rs 150 crore in Q1 FY27, which would be one of the strongest quarterly performances in the company’s history. Following the strong start to the year, the management has raised its FY27 revenue guidance by at least 10 percent to over Rs 660 crore from the earlier target of Rs 600 crore, targeting around 68.7 percent revenue growth by FY27 from its last year’s revenue base.
Strong Demand Across Global and Domestic Markets
The company said the higher revenue outlook is backed by better demand across international and domestic markets. It is seeing strong order visibility from private customers, institutions, and government tenders across several countries, along with the start of its long-term supply agreement with Partnership for Supply Chain Management (PFSCM), Netherlands.
Core Business and Consumer Segment Continue to Grow
Cupid added that its male condom and female condom businesses continue to perform well, supported by higher production capacity, new customer additions, and wider market reach. The lubricant business is also growing steadily, while the consumer wellness and personal care segment is expanding its presence through modern trade, organised retail, and pharmacy networks across India.
Capacity Expansion and New Businesses Support Future Growth
The company said it is investing in capacity expansion, operational improvements, and backward integration to support future growth and improve profitability. It is also participating in IVD kit and menstrual cup tenders across multiple states, while expecting its IVD business to become a meaningful growth driver over the long term through new product launches and regulatory approvals.
Chairman and Managing Director Aditya Kumar Halwasiya said the strong start to FY27 reflects the company’s transformation over the past few years into a diversified business with multiple growth drivers. He added that Cupid is seeing strong momentum in its international B2B business, backed by growing demand from private markets, institutional buyers, and government tenders, while its partnership with PFSCM has strengthened its long-term position in global healthcare procurement.
About the Company
Cupid Limited, a leading manufacturer & supplier of quality Male condoms, Female Condoms, water-based lubricant jelly & IVD kits, was incorporated in 1993. Its modern facility has a current capacity of over 480 million pieces of male condoms, 52 million pieces of female condoms & 210 million sachets of Lubricant Jelly per annum. Its manufacturing facility is located at Sinnar near Nashik, about 200 Km. East of Mumbai.
Financial Highlights: Revenue from operations of Rs 132 crore, up around 116 percent YoY from Q4 FY25 revenue of Rs 61 crore. The operating margin improved to 38 percent in Q4 FY26 from 30 percent in Q4 FY25. Net profit increased 200 percent YoY to Rs 36 crore in Q4 FY26, compared to Rs 12 crore in Q4 FY25, while earnings per share (EPS) rose 200 percent to Rs 0.27 in Q4 FY26 from Rs 0.09 per share in Q4 FY25.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
